Results 31 to 40 of about 141,167 (306)

The role of Tamoxifen in endometrial cancer [PDF]

open access: yes, 2023
This thesis explores the relationship between tamoxifen treatment in breast cancer and the risk of developing tamoxifen-induced endometrial cancer. Tamoxifen is a selective estrogen receptor modulator, meaning it acts as an estrogen antagonist in some ...
Chetty, Prayanka
core  

Treatment of Endometrial Cancer [PDF]

open access: yes, 2021
Endometrial cancer is currently the most common gynaecological tumour. This thesis is a review of the literature made available at the time of writing.
Ajoku, Benjamine
core  

Endometrial cancer following endometrial resection [PDF]

open access: yesGynecological Surgery, 2007
Endometrial ablation has emerged as a viable alternative to hysterectomy in the treatment of medically intractable dysfunctional uterine bleeding. However, this procedure cannot guarantee complete removal of the entire endometrium. Cases of endometrial cancer after endometrial ablation have been reported in the literature.
Giorgia Gaia   +10 more
openaire   +1 more source

Metabolically-defined body size phenotypes and risk of endometrial cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) [PDF]

open access: yes, 2022
Background: Obesity is a risk factor for endometrial cancer but whether metabolic dysfunction is associated with endometrial cancer independent of body size is not known.
Playdon, Mary C   +77 more
core   +2 more sources

Relationship between duration of breast feeding and endometrial cancer: a case-control study [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2020
Introduction: Endometrial cancer is the most common gynecologic malignancy in developed countries. The incidence of endometrial cancer is increasing in Iran. The risk of endometrial cancer is related to estrogen levels that breastfeeding reduces it. This
Zohreh Yeganeh   +5 more
doaj   +1 more source

ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas

open access: yesScientific Reports, 2021
In type 1 endometrial cancer, unopposed estrogen stimulation is thought to lead to endometrial hyperplasia which precedes malignant progression. Recent data from our group and others suggest that ALDH activity mediates stemness in endometrial cancer, but
Vei Mah   +8 more
doaj   +1 more source

Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk Loci [PDF]

open access: yes, 2019
The identification of target genes at genome-wide association study (GWAS) loci is a major obstacle for GWAS follow-up. To identify candidate target genes at the 16 known endometrial cancer GWAS risk loci, we performed HiChIP chromatin looping analysis ...
Dylan M. Glubb   +3 more
core   +1 more source

Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT

open access: yesAnimal Cells and Systems, 2021
Endometrial cancer is the most common gynecological cancer in the developed countries. Type II transmembrane serine proteases 4 (TMPRSS4) is a newly discovered transmembrane protein, which may be related to the invasion, metastasis of the tumor and the ...
Huan Xiao   +4 more
doaj   +1 more source

Predicting positive and negative impacts of cancer among long-term endometrial cancer survivors [PDF]

open access: yes, 2013
Objective Although the survival outcomes among women diagnosed with endometrial cancer are very favorable, little is known about the long-term impact of their cancer experience.
Obermair, Andreas   +7 more
core   +1 more source

Identify the predisposition genes to endometrial cancer [PDF]

open access: yes, 2019
[[abstract]]Endometrial carcinoma is the most dominant gynecological tumor worldwide. Familial risk of endometrial cancer has been reported but little is known about the predisposition genes.
Chiang, YC;Lee, TF;Lin, YF;Weng, HY;Tsai, SF;Wu, CW
core   +1 more source

Home - About - Disclaimer - Privacy